Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Towa Pharmaceutical Co Ltd
TSE:4553
Towa Pharmaceutical Co Ltd
TSE:4553
Price:
3 625
JPY
0.83%
Market Closed
Market Cap:
¥186.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
JP |
|
Prophecy International Holdings Ltd
ASX:PRO
|
AU |
|
Haidilao International Holding Ltd
F:8HI
|
CN |
Wall St Price Targets
Price Forecast
Based on 7 analysts
Based on 7 analysts
+56% Upside
from
¥3 625
today
Towa Pharmaceutical Co Ltd (4553)’s 12-month stock price forecast through September 2027 has a consensus target of ¥5 661, implying 56% upside. The forecast is based on price targets from 7 Wall Street analysts.
Analyst Rating
No ratings yet
No ratings yet
Towa Pharmaceutical Co Ltd Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Towa Pharmaceutical Co Ltd's stock price target?
Price Target
5 661
JPY
5 661
JPY
According to Wall Street analysts, the average 1-year price target for Towa Pharmaceutical Co Ltd is 5 661 JPY with a low forecast of 4 242 JPY and a high forecast of 6 195 JPY.
What is the Revenue forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Gross Profit forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 3 years is 9%.
What is the Pre-Tax Income forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
39%
39%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is 39%.
What is the Net Income forecast for Towa Pharmaceutical Co Ltd?
Projected CAGR
68%
68%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 68%.